📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
FREDUN PHARMACEUTICALS LIMITEDFREDUNPharmaceuticals
Open
2468.85
High
2560
Low
2467.85
Close
2552.75
Volume
14839
Exchange
bse
Time
21-May-2026

Outlook

Score:

6.25

Rating:

FAIR

Candlestick Pattern

CandlepatternofFredunPharmaceuticalsis
Marubozu
EstimatedStoplossofFredunPharmaceuticalsis
2467.85
FredunPharmaceuticalshasa
Bullishℹ
pattern.
Formationof
Marubozu
candlepatternindicatesFredunPharmaceuticalshaschancesof
Continuationℹ
ofthecurrenttrend.

Trend

FredunPharmaceuticalsisin
Sideways trendℹ
.
PriceofFredunPharmaceuticalsis
Upℹ
by

23.19

%.
Target
Buy@

1267.59

Sell@

2550.21

Current@

2552.75

Volume

ThetradevolumeofFredunPharmaceuticalshasbeen
Goodℹ
ThoughthevolumetrendforFredunPharmaceuticalsappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofFredunPharmaceuticalsis

Up

by

48.46

%

Valuation

ThecurrentmarketpriceofFredunPharmaceuticalsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth486crandtotalassetsworth486cr,thebalancesheetofFredunPharmaceuticalsis:
Balancedℹ
.
Cashflow
FredunPharmaceuticalshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 3cr

.Itis
Upℹ
by

250

%.
39.44% i.e. ₹ 28cr spent in operatingℹ
7.04% i.e. ₹ 5cr spent in investingℹ
53.52% i.e. ₹ 38cr earned in financingℹ
0% in otherℹ
FredunPharmaceuticalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 2cr

.Itis
Downℹ
by

300

%.
0% in operatingℹ
58.33% i.e. ₹ 7cr spent in investingℹ
41.67% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
TheincomeofFredunPharmaceuticalsis

₹ 167cr

and

Profit

is:

₹ 7cr

FredunPharmaceuticalsProfitisupby:

40

%andIncomeisUpby:

63.73

%
TheincomeofFredunPharmaceuticalsis

₹ 102cr

and

Profit

is:

₹ 5cr

FredunPharmaceuticalsProfitisupby:

25

%andIncomeisDownby:

4.67

%
TheincomeofFredunPharmaceuticalsis

₹ 107cr

and

Profit

is:

₹ 4cr

FredunPharmaceuticalsProfitisupby:

0

%andIncomeisUpby:

37.18

%
By using this site you agree to the use of cookies to deliver a better site experience.